(Q35028706)

5 August 2017

1 reference

title

Neurobiology of depression and anxiety in Parkinson's disease (English)

1 reference

5 August 2017

1 reference

1 reference

Osamu Kano

1

1 reference

5 August 2017

Ken Ikeda

2

1 reference

5 August 2017

Derek Cridebring

3

1 reference

5 August 2017

Takanori Takazawa

4

1 reference

5 August 2017

Yasuhiro Yoshii

5

1 reference

5 August 2017

Yasuo Iwasaki

6

1 reference

5 August 2017

12 May 2011

1 reference

5 August 2017

1 reference

5 August 2017

2011

1 reference

5 August 2017

143547

1 reference

Creative Commons Attribution 3.0 Unported

5 August 2017

start time

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Occurrence of depression and anxiety prior to Parkinson's disease.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Anxious personality predicts an increased risk of Parkinson's disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

When does Parkinson disease start?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Anxiety disorders in Parkinson's disease: prevalence and risk factors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Neuropsychiatric symptoms in Parkinson's disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Use of antidepressants and the risk of Parkinson's disease: a prospective study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

A controlled trial of antidepressants in patients with Parkinson disease and depression

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Beneficial effect of pramipexole for motor function and depression in Parkinson's disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Early Parkinson's disease and non-motor issues

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Quality of life and depression in Parkinson's disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Non-motor symptoms of Parkinson's disease: diagnosis and management

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Current approaches to management of depression in Parkinson's Disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Increased risk of Parkinson's disease after depression: a retrospective cohort study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

An essay on the shaking palsy. 1817.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Neurobiological mechanisms of social anxiety disorder

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Association of coffee and caffeine intake with the risk of Parkinson disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Review of community prevalence of depression in later life

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Depression in patients with Parkinson's disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Mental disorders from low-dose bromocriptine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Non-recognition of depression and other non-motor symptoms in Parkinson's disease.

8 July 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F143547

Parkinson disease: Depression and anxiety in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F143547

Prospective study of phobic anxiety and risk of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F143547

The quality of life in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F143547

Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F143547

Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F143547

Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F143547

Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F143547

Brain mechanisms of social anxiety disorder.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109308

Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia

25 October 2018

1 reference

https://api.crossref.org/works/10.4061%2F2011%2F143547

Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21687804

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21687804

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/21687804

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4061/2011/143547

1 reference

5 August 2017

1 reference

5 August 2017

1 reference